Mohammad Rashid PhD

Mohammad Abdur Rashid's graduate background is in Redox Biology and pancreatic β-cells and his current work focuses on the early development of neurogenesis in neural stem cells at cellular and molecular level. He obtained his Ph.D. in Biochemistry and Molecular Biology at the Kyung Hee University, South Korea, in February 2011. His Ph.D. manuscript has been published in Free Radical Biology & Medicine entitled "Carbonyl reductase 1 protects pancreatic ß-cells against oxidative stress-induced apoptosis in glucotoxicity and glucolipotoxicity", and another manuscript published in Cell Physiol Biochem entitled" Mitochondria-targeted Antioxidants Protect Pancreatic ß-cells against Oxidative Stress and Improve Insulin Secretion in Glucotoxicity and Glucolipotoxicity".

He started his post-doctoral training in the Lab of Molecular Signaling, NIAAA on February 08, 2011. Recently, his manuscript was published in the Journal of Neurochemistry entitled " N-Docosahexaenoylethanolamine is a potent neurogenic factor for neural Stem cell Differentiation". He worked on the molecular mechanism of docosahexaenoic acid (DHA) endogenous metabolite, N-docosahexaenoylethanolamine (synaptamide) involved in G-protein-coupled receptors (GPCRs) signaling, particularly during neurodevelopment and function in neural stem cells. He also worked on how ethanol exposure impairs neuronal differentiation of neural stem cells while synaptamide ameliorates the adverse impact of ethanol by counter-affecting shared targets in the GPCR signaling system including Gs alpha, adenylyl cyclase, and PDE4.